Takeda Pharmaceutical Company Limited Operating Cash Flow for the year ending March 31, 2025: USD 6.42 B

Takeda Pharmaceutical Company Limited Operating Cash Flow is USD 6.42 B for the year ending March 31, 2025, a 35.56% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Takeda Pharmaceutical Company Limited Operating Cash Flow for the year ending March 31, 2024 was USD 4.73 B, a -35.65% change year over year.
  • Takeda Pharmaceutical Company Limited Operating Cash Flow for the year ending March 31, 2023 was USD 7.36 B, a -20.28% change year over year.
  • Takeda Pharmaceutical Company Limited Operating Cash Flow for the year ending March 31, 2022 was USD 9.23 B, a 1.07% change year over year.
  • Takeda Pharmaceutical Company Limited Operating Cash Flow for the year ending March 31, 2021 was USD 9.13 B, a 46.57% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities